DSIP
Peptide researched for sleep quality and recovery.
DSIP
Background
Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated from the cerebral venous blood of sleeping rabbits. It has been studied for influences on sleep architecture, neuroendocrine regulation, and stress responses, though its precise receptor target and physiological role remain incompletely defined.
The literature spans several decades but is characterized by heterogeneous findings; DSIP remains a research compound without an established clinical application.
Selected literature
- Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neuroscience and Biobehavioral Reviews. 1984;8(1):83-93.
- Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. Journal of Neurochemistry. 2006;97(2):303-309.
- Dick P, et al. DSIP in the treatment of withdrawal syndromes from alcohol and opiates. European Neurology. 1984;23(5):364-371.
References are provided for scientific context only. Citation does not imply endorsement of any use, nor a claim of safety or efficacy. Findings frequently derive from in-vitro or animal models.
Trademarks & attribution
Delta sleep-inducing peptide is a naturally described neuropeptide with no registered pharmaceutical trademark or approved drug product. Supplied as reference material only.
